NCT05944887

Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

Does Intravenous Lidocaine Reduce Propofol Consumption and the Side Effects of Sedation During Gastroscopy in ASA 1 and 2 Patients.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: Erasme University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to assess if intravenous administration of linisol reduce the propofol consumption and the sides effects of sedation during gastroscopy in healthy patients (ASA 1 and 2 patients). Prior to propofol sedation, participants will receive either an intravenous bolus of linisol (1.5 mg/kg) = treated group or placebo = control group. After the gastroscopy, patients will be asked to complete a satisfaction questionnaire

Conditions

• Diagnostic Gastroscopy

Interventions

Type	Name	Description
DRUG	Lidocaine 2% Injectable Solution	administration of a bolus of lidocaine 1.5 mg/kg
DRUG	Saline administration as placebo	administration of a bolus of saline solution as a placebo
DRUG	Propofol injection	Sedation by total intravenous administration (TIVA) of propofol
PROCEDURE	gastroscopy	esogastroduodenoscopy

Timeline

• Start date: 2023-07-21
• Primary completion: 2023-08-21
• Completion: 2023-08-25
• First posted: 2023-07-13
• Last updated: 2023-09-18

Locations

1 site across 1 country: Belgium